6.3.2.4: D-Alanine-D-alanine ligase
This is an abbreviated version!
For detailed information about D-Alanine-D-alanine ligase, go to the full flat file.
Word Map on EC 6.3.2.4
-
6.3.2.4
-
peptidoglycan
-
vancomycin
-
enterococci
-
d-cycloserine
-
vancomycin-resistant
-
faecium
-
d-alanyl-d-lactate
-
teicoplanin
-
depsipeptide
-
d-ala-d-lac
-
drug development
-
vanrs
-
atp-grasp
-
vancomycin-dependent
-
vand-type
-
d-ala-d-lactate
-
d-ala2
-
analysis
-
synthesis
- 6.3.2.4
- peptidoglycan
- vancomycin
-
enterococci
- d-cycloserine
-
vancomycin-resistant
- faecium
-
d-alanyl-d-lactate
- teicoplanin
-
depsipeptide
- d-ala-d-lac
- drug development
-
vanrs
-
atp-grasp
-
vancomycin-dependent
-
vand-type
- d-ala-d-lactate
-
d-ala2
- analysis
- synthesis
Reaction
Synonyms
AbDDL, ATP-dependent D-Ala:D-Ala ligase, BBR47_20440, BMD_0213, BMQ_0219, BMWSH_5013, D-Ala-D-Ala ligase, D-Ala-D-Ala synthetase, D-Ala:D-Ala ligase, D-alanine:D-alanine (D-lactate) ligase (ADP), D-Alanine:D-alanine ligase, D-alanyl-D-alanine ligase B, D-Alanyl-D-alanine synthetase, D-Alanylalanine synthetase, DD1, DDI, Ddl, DdlA, DdlB, DdlB ligase, dll, dllB, EcDdlB, More, Rv2981c, SsDdl, Synthetase, D-alanylalanine, Tb-DdlA, TmDdl, TtDdL, TTHA1587, VanA, VanB ligase, YpDDL
ECTree
Advanced search results
Application
Application on EC 6.3.2.4 - D-Alanine-D-alanine ligase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
analysis
drug development
synthesis
Thermosynechococcus vestitus
-
D-alanine-D-alanine ligase is a biocatalyst for synthesizing D-amino acid dipeptides, use of a thermostable ATP regeneration system
-
assay method for screening for effectors of alanine racemase and/or D-alanine:D-alanine ligase
analysis
Enterococcus faecalis R / ATCC 8043
-
assay method for screening for effectors of alanine racemase and/or D-alanine:D-alanine ligase
-
the enzyme is a target for antibiotic inhibitor development, overview
drug development
-
the enzyme is an attractive and viable target in the search for effective antimicrobial drugs
drug development
-
the enzyme is an attractive target for development of antimicrobial drugs
drug development
DDL is an important drug target for the development of antibacterial agents
drug development
the enzyme is a target for drug development to combat against Mycobacterium tuberculosis (Mtb)
drug development
-
the enzyme is a target for drug development. Acinetobacter baumannii is emerging as a multidrug-resistant nosocomial pathogen, that causes a number of diseases, including pneumonia, bacteremia, meningitis, and skin infections
drug development
Mycobacterium tuberculosis ATCC 25618 / H37Rv
-
the enzyme is a target for drug development to combat against Mycobacterium tuberculosis (Mtb)
-